10
Views
5
CrossRef citations to date
0
Altmetric
Case Reports

Primary Malignant Fibrous Histiocytoma of the Spleen-an Extremely Rare Entity

, &
Pages 558-560 | Published online: 11 Mar 2016

References

  • Enzinger F. M., Weiss S. W. Malignant fibrohistiocytic tumours. In: Soft tissue tumours 3rd ed. St. Louis: C.V. Mosby, 1995: 351–380.
  • Bonilla F., Provencio M., Fernandez E., Espana P. Malignant fibrous histiocytoma of the spleen and chronic myelogenous leukaemia. A case report. Oncology, 1994, 51 (5): 465–466.
  • Colovic N., Cemerikic-Martinovic V., Colovic R., zogovic S. Primary malignant fibrous histiocytoma of the spleen and liver. Med Oncol, 2001, 18 (4): 293–297.
  • Govoni E., Bazzocchi F., Pileri S., Martinelli G. Primary malignant fibrous histiocytoma of the spleen: an ultrastructural study. Histopathology, 1982, 6 (3): 351–361.
  • Lieu P. K., Ho J., Ng H. S. Primary malignant fibrous histiocytoma of the spleen and liver-a case report. Ann Acad Med Singapore, 1993, 22 (3): 390–392.
  • Mallipudi B. V., Chawdhery M. घ., Jeffery P. J. Primary malignant fibrous histiocytoma of the spleen. Eur J Surg Oncol, 1998, 24 (5): 448–449.
  • Sieber S. C., Lopez V., Rosai J., Buckley P. J. Primary tumour of the spleen with morphologic features of malignant fibrous histiocytoma. Immunohistochemical evidence for a macrophage origin. Am J Surg Pathol, 1990, 14 (11): 1061–1070.
  • Wick M. R., Scheithauer B. W., Smith S. L., Beart R. W. Jr. Primary non-lymphoreticular malignant neoplasms of the spleen. Am J Surg Pathol, 1982, 6 (3): 229–242.
  • Kenney R. J., Cheney R., Stull M. A., Kraybill W. Soft tissue sarcomas: current management and future directions. Surg Clin North Am, 2009, 89 (1): 235–247, x.
  • Ioannidis J. P, Lau J. 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J Nucl Med, 2003, 44 (5): 717–724.
  • In: AJCC Cancer Staging Handbook. 6th ed (2002) 22 Soft Tissue Sarcoma.
  • DeMatteo R. P., Lewis J. J., Leung D., Mudan S. S., Woodruff J. M., Brennan M. F. Two hundred gastro-intestinal stromal tumours: recurrence patterns and prognostic factors for survival. Ann Surg, 2000, 231 (1): 51–58.
  • Lee Y. T. Leiomyosarcoma of the gastro-intestinal tract: general pattern of metastasis and recurrence. Cancer Treat Rev, 1983, 10 (2): 91–101.
  • NgE. H., Pollock R. E., Romsdahl M. M. Prognostic implications of patterns of failure for gastro-intestinal leiomyosarcomas. Cancer, 1992, 69 (6): 1334–1341.
  • Edmonson J. H., Ryan L. M., Blum R. H., Brooks J. S., ShirakiM., Frytak S., Parkinson D. R. Randomised comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mito-mycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol, 1993, 11 (7): 1269–1275.
  • Frustaci S., Gherlinzoni F., De Paoli A., Bonetti M., AzzarelliA., Comandone A., Olmi P., Buonadonna A., PignattiG., Barbieri E., Apice G., Zmerly H., Serraino D., Picci P. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the italian randomised cooperative trial. J Clin Oncol, 2001, 19 (5): 1238–1247.
  • Alektiar K. M., Hu K., Anderson L., Brennan M. F., Harrison L. B. High-dose-rate intra-operative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys, 2000, 47 (1): 157–163.
  • Rajan D. K., Soulen M. C., Clark T. W., Baum R. A., HaskalZ. J., Shlansky-Goldberg R. D., Freiman D. B. Sarcomas metastatic to the liver: response and survival after cisplatin, dox-orubicin, mitomycin-C, Ethiodol, and polyvinyl alcohol chemo-embolisation. J Vasc Interv Radiol, 2001, 12 (2): 187–193.
  • CoiNDRE J. M. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med, 2006, 130 (10): 1448–1453.
  • Kattan M. W., Leung D. H., Brennan M. F. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol, 2002, 20 (3): 791–796.
  • Eilber F. C., Brennan M. F., Eilber F. R., Dry S. M., Singer S., Kattan M. W. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer, 2004, 101 (10): 22702275.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.